skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 857  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Material Type:
Article
Add to My Research

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

Circulation (New York, N.Y.), 2015-06, Vol.131 (22), p.1981-1988 [Peer Reviewed Journal]

2015 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;2015 American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.114.013777 ;PMID: 25948538

Full text available

2
Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and Opportunities
Material Type:
Article
Add to My Research

Prevention of Anthracycline-Induced Cardiotoxicity: Challenges and Opportunities

Journal of the American College of Cardiology, 2014-09, Vol.64 (9), p.938-945 [Peer Reviewed Journal]

2015 INIST-CNRS ;Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2014.06.1167 ;PMID: 25169180 ;CODEN: JACCDI

Full text available

3
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Material Type:
Article
Add to My Research

Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol

European heart journal, 2016-06, Vol.37 (21), p.1671-1680 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. ;The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology 2016 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw022 ;PMID: 26903532

Full text available

4
Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention
Material Type:
Article
Add to My Research

Cardiovascular Disease in Survivors of Childhood Cancer: Insights Into Epidemiology, Pathophysiology, and Prevention

Journal of clinical oncology, 2018-07, Vol.36 (21), p.2135-2144 [Peer Reviewed Journal]

2018 by American Society of Clinical Oncology 2018 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2017.76.3920 ;PMID: 29874141

Full text available

5
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Material Type:
Article
Add to My Research

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

CA: a cancer journal for clinicians, 2016-07, Vol.66 (4), p.309-325 [Peer Reviewed Journal]

2016 American Cancer Society, Inc. ;Copyright Wiley Subscription Services, Inc. Jul-Aug 2016 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21341 ;PMID: 26919165 ;CODEN: CAMCAM

Full text available

6
Cardioprotective interventions for cancer patients receiving anthracyclines
Material Type:
Article
Add to My Research

Cardioprotective interventions for cancer patients receiving anthracyclines

Cochrane database of systematic reviews, 2008-01 (2), p.CD003917 [Peer Reviewed Journal]

EISSN: 1469-493X ;DOI: 10.1002/14651858.CD003917.pub3 ;PMID: 18425895

Full text available

7
Anthracycline Chemotherapy and Cardiotoxicity
Material Type:
Article
Add to My Research

Anthracycline Chemotherapy and Cardiotoxicity

Cardiovascular drugs and therapy, 2017-02, Vol.31 (1), p.63-75 [Peer Reviewed Journal]

The Author(s) 2017 ;Cardiovascular Drugs and Therapy is a copyright of Springer, 2017. ;ISSN: 0920-3206 ;EISSN: 1573-7241 ;DOI: 10.1007/s10557-016-6711-0 ;PMID: 28185035 ;CODEN: CDTHET

Full text available

8
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
Material Type:
Article
Add to My Research

Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis

Journal of clinical oncology, 2016-09, Vol.34 (26), p.3157-3165 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;Distributed under a Creative Commons Attribution 4.0 International License ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.67.4846 ;PMID: 27458291

Full text available

9
Anthracyclines / Trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Material Type:
Article
Add to My Research

Anthracyclines / Trastuzumab: new aspects of cardiotoxicity and molecular mechanisms

Trends in pharmacological sciences (Regular ed.), 2015-06, Vol.36 (6), p.326-348 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0165-6147 ;EISSN: 1873-3735 ;DOI: 10.1016/j.tips.2015.03.005 ;PMID: 25895646

Digital Resources/Online E-Resources

10
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Material Type:
Article
Add to My Research

Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group

The lancet oncology, 2015-03, Vol.16 (3), p.e123-e136 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 2015 ;2015 Elsevier Ltd. All rights reserved. Elsevier Ltd. All rights reserved. 2015 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(14)70409-7 ;PMID: 25752563 ;CODEN: LANCAO

Full text available

11
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Material Type:
Article
Add to My Research

Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention

Heart (British Cardiac Society), 2018-06, Vol.104 (12), p.971-977 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2017-312103 ;PMID: 29217634

Full text available

12
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
Material Type:
Article
Add to My Research

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines

Blood, 2017-04, Vol.129 (16), p.2257-2265 [Peer Reviewed Journal]

2017 American Society of Hematology ;2017 by The American Society of Hematology. ;2017 by The American Society of Hematology 2017 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2016-09-740332 ;PMID: 28143884

Full text available

13
Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study
Material Type:
Article
Add to My Research

Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study

Journal of clinical oncology, 2019-05, Vol.37 (13), p.1090-1101 [Peer Reviewed Journal]

2019 by American Society of Clinical Oncology 2019 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.18.01764 ;PMID: 30860946

Full text available

14
Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study
Material Type:
Article
Add to My Research

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

Annals of oncology, 2018-03, Vol.29 (3), p.646-653 [Peer Reviewed Journal]

2017 THE AUTHORS ;The Author(s) 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2017 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdx773 ;PMID: 29253081

Full text available

15
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Material Type:
Article
Add to My Research

Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells

Immunity (Cambridge, Mass.), 2013-04, Vol.38 (4), p.729-741 [Peer Reviewed Journal]

2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Apr 18, 2013 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2013.03.003 ;PMID: 23562161

Full text available

16
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)
Material Type:
Article
Add to My Research

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

Annals of oncology, 2013-09, Vol.24 (9), p.2278-2284 [Peer Reviewed Journal]

2013 European Society for Medical Oncology ;2014 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdt182 ;PMID: 23704196

Full text available

17
Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity
Material Type:
Article
Add to My Research

Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity

The American journal of cardiology, 2013-12, Vol.112 (12), p.1980-1984 [Peer Reviewed Journal]

Elsevier Inc. ;2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 15, 2013 ;ISSN: 0002-9149 ;EISSN: 1879-1913 ;DOI: 10.1016/j.amjcard.2013.08.026 ;PMID: 24075281 ;CODEN: AJCDAG

Full text available

18
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Material Type:
Article
Add to My Research

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

The New England journal of medicine, 2011-10, Vol.365 (14), p.1273-1283 [Peer Reviewed Journal]

Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Copyright © 2011 Massachusetts Medical Society 2011 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa0910383 ;PMID: 21991949 ;CODEN: NEJMAG

Full text available

19
Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study
Material Type:
Article
Add to My Research

Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study

Circulation (New York, N.Y.), 2023-02, Vol.147 (7), p.532-545 [Peer Reviewed Journal]

ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.122.062814 ;PMID: 36342348

Full text available

20
Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)
Material Type:
Article
Add to My Research

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)

Clinical cancer research, 2021-02, Vol.27 (4), p.975-982 [Peer Reviewed Journal]

2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-20-3646 ;PMID: 33208340

Full text available

Results 1 - 20 of 857  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (834)

Refine My Results

Creation Date 

From To
  1. Before 2001  (13)
  2. 2001 To 2006  (88)
  3. 2007 To 2012  (267)
  4. 2013 To 2019  (335)
  5. After 2019  (155)
  6. More options open sub menu

Resource Type 

  1. Articles  (856)
  2. magazinearticle  (1)
  3. More options open sub menu

Language 

  1. English  (843)
  2. Japanese  (130)
  3. Portuguese  (14)
  4. French  (4)
  5. Polish  (3)
  6. Russian  (3)
  7. Norwegian  (3)
  8. Spanish  (3)
  9. Hungarian  (1)
  10. German  (1)
  11. Turkish  (1)
  12. Slovak  (1)
  13. Czech  (1)
  14. More options open sub menu

Searching Remote Databases, Please Wait